David G. Coffey

Oncology

1475 NW 12th Ave
Miami, FL 33136

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Enhanced BCMA Antigen Density Increases Trogocytosis and Attenuates CAR T cell Function.

Enhanced BCMA Antigen Density Increases Trogocytosis and Attenuates CAR T cell Function.

Journal: bioRxiv : the preprint server for biology

Published: July 29, 2026

Navigating the Therapeutic Landscape of Multiple Myeloma: Immunotherapy, Microenvironment, and Resistance.

Navigating the Therapeutic Landscape of Multiple Myeloma: Immunotherapy, Microenvironment, and Resistance.

Journal: Biomedicines

Published: May 27, 2026

Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.

Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.

Journal: HemaSphere

Published: January 13, 2026

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Emerging technologies for minimal residual disease detection in hematologic malignancies.

Emerging technologies for minimal residual disease detection in hematologic malignancies.

Journal: Seminars in hematology

Published: November 16, 2025

Editorial: Single-cell sequencing of the immune microenvironment in cancer.

Editorial: Single-cell sequencing of the immune microenvironment in cancer.

Journal: Frontiers in immunology

Published: July 07, 2025

Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials.

Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials.

Journal: Transplantation and cellular therapy

Published: May 18, 2025

Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controls.

Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controls.

Journal: PloS one

Published: April 22, 2025

Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies.

Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies.

Journal: Blood advances

Published: April 21, 2025

RHOA Loss of Function Impairs the IFNγ Response and Promotes CD19 Antigen Escape to Drive CAR-T Resistance in Diffuse Large B-cell Lymphoma.

RHOA Loss of Function Impairs the IFNγ Response and Promotes CD19 Antigen Escape to Drive CAR-T Resistance in Diffuse Large B-cell Lymphoma.

Journal: bioRxiv : the preprint server for biology

Published: March 17, 2025

Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study.

Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study.

Journal: Haematologica

Published: December 12, 2024

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.

Journal: Blood

Published: November 13, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026